Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
11.56
+0.21 (1.85%)
At close: Dec 20, 2024, 4:00 PM
11.70
+0.14 (1.21%)
After-hours: Dec 20, 2024, 6:34 PM EST
Rocket Pharmaceuticals Employees
Rocket Pharmaceuticals had 268 employees as of December 31, 2023. The number of employees increased by 28 or 11.67% compared to the previous year.
Employees
268
Change (1Y)
28
Growth (1Y)
11.67%
Revenue / Employee
n/a
Profits / Employee
-$962,981
Market Cap
1.05B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
OPKO Health | 3,930 |
Tilray Brands | 2,650 |
ANI Pharmaceuticals | 642 |
Vir Biotechnology | 587 |
Bicycle Therapeutics | 284 |
Collegium Pharmaceutical | 197 |
Pharvaris | 82 |
RCKT News
- 2 days ago - Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' - Investopedia
- 10 days ago - Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
- 10 days ago - Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock - Business Wire
- 25 days ago - Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference - Business Wire
- 4 weeks ago - Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst - Benzinga
- 4 weeks ago - Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference - Business Wire
- 5 weeks ago - Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association's 2024 Late-Breaking Science Sessions - Business Wire
- 6 weeks ago - Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference - Business Wire